Angiogenesis Modulators Market Report

Europe Angiogenesis Modulators Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 19, 2019
  • PAGES：160
  • REPORT CODE：GMM386843
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Angiogenesis Modulators market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Angiogenesis Modulators Market Segmentations:

    By Player:

    • Angiotech Pharmaceuticals, Inc

    • Genzyme Corporation

    • Abbott Laboratories

    • Amgen, Inc

    • Genvec, Inc.

    • Eye-Tech Inc.

    • Silence Therapeutics plc

    • Entremed, Inc

    • ThromboGenics, Inc.

    • Aeterna Zentaris Inc.

    • Ångstrom Pharmaceuticals, Inc

    • Chugai Pharmaceutical Co., Ltd.

    • Alcon, Inc

    • Astrazeneca plc.

    • Cardium Therapeutics, Inc

    • Chugai Pharmaceutical Co, Ltd

    • Genentech, Inc.

    • Eli Lilly and Company

    • F.Hoffmann-La Roche Ltd

    • Eisai, Inc

    • Antisoma plc.

    • Celgene Corporation

    • Imclone Systems, Inc

    • Merck & Co., Inc.

    • GlaxoSmithKline plc

    • Bayer Healthcare AG

    • Merck & Co, Inc.

    • Progen Pharmaceuticals Ltd.

    • Bristol-Myers Squibb Company

    By Type:

    • Angiogenesis Inhibitors

    • Angiogenesis Stimulators

    • Angiogenin

    • Others

    By End-User:

    • Cancer

    • Cardiology

    • Ophthalmology

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Angiogenesis Modulators Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Inhibitors from 2014 to 2026

    • 1.3.2 Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Stimulators from 2014 to 2026

    • 1.3.3 Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenin from 2014 to 2026

    • 1.3.4 Europe Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Angiogenesis Modulators Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.2 Europe Angiogenesis Modulators Market Size and Growth Rate of Cardiology from 2014 to 2026

    • 1.4.3 Europe Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • 1.4.4 Europe Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Angiogenesis Modulators Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Angiogenesis Modulators by Major Types

      • 3.4.1 Market Size and Growth Rate of Angiogenesis Inhibitors

      • 3.4.2 Market Size and Growth Rate of Angiogenesis Stimulators

      • 3.4.3 Market Size and Growth Rate of Angiogenin

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Angiogenesis Modulators Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Angiogenesis Modulators by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Angiogenesis Modulators for Cancer

      • 4.4.2 Market Size and Growth Rate of Angiogenesis Modulators for Cardiology

      • 4.4.3 Market Size and Growth Rate of Angiogenesis Modulators for Ophthalmology

      • 4.4.4 Market Size and Growth Rate of Angiogenesis Modulators for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Angiogenesis Modulators Production Analysis by Top Regions

    • 5.2 Europe Angiogenesis Modulators Consumption Analysis by Top Regions

    • 5.3 Europe Angiogenesis Modulators Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.3 France Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    6 Product Circulation of Angiogenesis Modulators Market among Top Countries

    • 6.1 Top 5 Export Countries in Angiogenesis Modulators Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Angiogenesis Modulators Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Angiogenesis Modulators Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Angiogenesis Modulators Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Angiogenesis Modulators Landscape Analysis

    • 7.1 Germany Angiogenesis Modulators Landscape Analysis by Major Types

    • 7.2 Germany Angiogenesis Modulators Landscape Analysis by Major End-Users

    8. UK Angiogenesis Modulators Landscape Analysis

    • 8.1 UK Angiogenesis Modulators Landscape Analysis by Major Types

    • 8.2 UK Angiogenesis Modulators Landscape Analysis by Major End-Users

    9. France Angiogenesis Modulators Landscape Analysis

    • 9.1 France Angiogenesis Modulators Landscape Analysis by Major Types

    • 9.2 France Angiogenesis Modulators Landscape Analysis by Major End-Users

    10. Italy Angiogenesis Modulators Landscape Analysis

    • 10.1 Italy Angiogenesis Modulators Landscape Analysis by Major Types

    • 10.2 Italy Angiogenesis Modulators Landscape Analysis by Major End-Users

    11. Spain Angiogenesis Modulators Landscape Analysis

    • 11.1 Spain Angiogenesis Modulators Landscape Analysis by Major Types

    • 11.2 Spain Angiogenesis Modulators Landscape Analysis by Major End-Users

    12. Poland Angiogenesis Modulators Landscape Analysis

    • 12.1 Poland Angiogenesis Modulators Landscape Analysis by Major Types

    • 12.2 Poland Angiogenesis Modulators Landscape Analysis by Major End-Users

    13. Russia Angiogenesis Modulators Landscape Analysis

    • 13.1 Russia Angiogenesis Modulators Landscape Analysis by Major Types

    • 13.2 Russia Angiogenesis Modulators Landscape Analysis by Major End-Users

    14. Switzerland Angiogenesis Modulators Landscape Analysis

    • 14.1 Switzerland Angiogenesis Modulators Landscape Analysis by Major Types

    • 14.2 Switzerland Angiogenesis Modulators Landscape Analysis by Major End-Users

    15. Turkey Angiogenesis Modulators Landscape Analysis

    • 15.1 Turkey Angiogenesis Modulators Landscape Analysis by Major Types

    • 15.2 Turkey Angiogenesis Modulators Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Landscape Analysis by Top Countries

      • 16.3.1 Denmark Angiogenesis Modulators Market Volume and Growth Rate

      • 16.3.2 Finland Angiogenesis Modulators Market Volume and Growth Rate

      • 16.3.3 Norway Angiogenesis Modulators Market Volume and Growth Rate

      • 16.3.4 Sweden Angiogenesis Modulators Market Volume and Growth Rate

      • 16.3.6 Iceland Angiogenesis Modulators Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Landscape Analysis by Top Countries

      • 17.3.1 Belgium Angiogenesis Modulators Market Volume and Growth Rate

      • 17.3.2 Netherlands Angiogenesis Modulators Market Volume and Growth Rate

      • 17.3.3 Luxembourg Angiogenesis Modulators Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Landscape Analysis by Top Countries

      • 18.3.1 Estonia Angiogenesis Modulators Market Volume and Growth Rate

      • 18.3.2 Latvia Angiogenesis Modulators Market Volume and Growth Rate

      • 18.3.3 Lithuania Angiogenesis Modulators Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Angiotech Pharmaceuticals, Inc

      • 19.1.1 Angiotech Pharmaceuticals, Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Genzyme Corporation

      • 19.2.1 Genzyme Corporation Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Abbott Laboratories

      • 19.3.1 Abbott Laboratories Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Amgen, Inc

      • 19.4.1 Amgen, Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Genvec, Inc.

      • 19.5.1 Genvec, Inc. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Eye-Tech Inc.

      • 19.6.1 Eye-Tech Inc. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Silence Therapeutics plc

      • 19.7.1 Silence Therapeutics plc Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Entremed, Inc

      • 19.8.1 Entremed, Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 ThromboGenics, Inc.

      • 19.9.1 ThromboGenics, Inc. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Aeterna Zentaris Inc.

      • 19.10.1 Aeterna Zentaris Inc. Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Ångstrom Pharmaceuticals, Inc

      • 19.11.1 Ångstrom Pharmaceuticals, Inc Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Chugai Pharmaceutical Co., Ltd.

      • 19.12.1 Chugai Pharmaceutical Co., Ltd. Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Alcon, Inc

      • 19.13.1 Alcon, Inc Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Astrazeneca plc.

      • 19.14.1 Astrazeneca plc. Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Cardium Therapeutics, Inc

      • 19.15.1 Cardium Therapeutics, Inc Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Chugai Pharmaceutical Co, Ltd

      • 19.16.1 Chugai Pharmaceutical Co, Ltd Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Genentech, Inc.

      • 19.17.1 Genentech, Inc. Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Eli Lilly and Company

      • 19.18.1 Eli Lilly and Company Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 F.Hoffmann-La Roche Ltd

      • 19.19.1 F.Hoffmann-La Roche Ltd Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Eisai, Inc

      • 19.20.1 Eisai, Inc Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Antisoma plc.

      • 19.21.1 Antisoma plc. Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Celgene Corporation

      • 19.22.1 Celgene Corporation Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Imclone Systems, Inc

      • 19.23.1 Imclone Systems, Inc Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Merck & Co., Inc.

      • 19.24.1 Merck & Co., Inc. Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 GlaxoSmithKline plc

      • 19.25.1 GlaxoSmithKline plc Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Bayer Healthcare AG

      • 19.26.1 Bayer Healthcare AG Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    • 19.27 Merck & Co, Inc.

      • 19.27.1 Merck & Co, Inc. Company Profile and Development Status

      • 19.27.2 Market Performance

      • 19.27.3 Product and Service Introduction

    • 19.28 Progen Pharmaceuticals Ltd.

      • 19.28.1 Progen Pharmaceuticals Ltd. Company Profile and Development Status

      • 19.28.2 Market Performance

      • 19.28.3 Product and Service Introduction

    • 19.29 Bristol-Myers Squibb Company

      • 19.29.1 Bristol-Myers Squibb Company Company Profile and Development Status

      • 19.29.2 Market Performance

      • 19.29.3 Product and Service Introduction

    The List of Tables and Figures (Totals 96 Figures and 110 Tables)

    • Figure Product Picture

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Inhibitors from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Stimulators from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Angiogenin from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • Figure Europe Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure UK Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure France Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Angiogenesis Modulators Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Angiogenesis Modulators Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Angiogenesis Modulators

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Angiogenesis Modulators by Different Types from 2014 to 2026

    • Table Consumption Share of Angiogenesis Modulators by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Angiogenesis Inhibitors

    • Figure Market Size and Growth Rate of Angiogenesis Stimulators

    • Figure Market Size and Growth Rate of Angiogenin

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Angiogenesis Modulators by Different End-Users from 2014 to 2026

    • Table Consumption Share of Angiogenesis Modulators by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Ophthalmology

    • Figure Market Size and Growth Rate of Others

    • Table Europe Angiogenesis Modulators Production by Major Regions

    • Table Europe Angiogenesis Modulators Production Share by Major Regions

    • Figure Europe Angiogenesis Modulators Production Share by Major Countries and Regions in 2014

    • Table Europe Angiogenesis Modulators Consumption by Major Regions

    • Table Europe Angiogenesis Modulators Consumption Share by Major Regions

    • Table Germany Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table UK Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table France Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Italy Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Spain Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Poland Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Russia Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Switzerland Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Turkey Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Angiogenesis Modulators Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Germany Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Germany Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Germany Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table UK Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table UK Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table UK Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table UK Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table France Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table France Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table France Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table France Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Italy Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Italy Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Italy Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Italy Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Spain Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Spain Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Spain Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Spain Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Poland Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Poland Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Poland Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Poland Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Russia Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Russia Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Russia Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Russia Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Switzerland Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Switzerland Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Switzerland Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Turkey Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Turkey Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Turkey Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Angiogenesis Modulators Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Angiogenesis Modulators Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Angiogenesis Modulators Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Angiogenesis Modulators Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Angiotech Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angiotech Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Angiotech Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Angiotech Pharmaceuticals, Inc

    • Table Product and Service Introduction of Angiotech Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Genzyme Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corporation

    • Figure Sales and Growth Rate Analysis of Genzyme Corporation

    • Figure Revenue and Market Share Analysis of Genzyme Corporation

    • Table Product and Service Introduction of Genzyme Corporation

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Amgen, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc

    • Figure Sales and Growth Rate Analysis of Amgen, Inc

    • Figure Revenue and Market Share Analysis of Amgen, Inc

    • Table Product and Service Introduction of Amgen, Inc

    • Table Company Profile and Development Status of Genvec, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genvec, Inc.

    • Figure Sales and Growth Rate Analysis of Genvec, Inc.

    • Figure Revenue and Market Share Analysis of Genvec, Inc.

    • Table Product and Service Introduction of Genvec, Inc.

    • Table Company Profile and Development Status of Eye-Tech Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eye-Tech Inc.

    • Figure Sales and Growth Rate Analysis of Eye-Tech Inc.

    • Figure Revenue and Market Share Analysis of Eye-Tech Inc.

    • Table Product and Service Introduction of Eye-Tech Inc.

    • Table Company Profile and Development Status of Silence Therapeutics plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics plc

    • Figure Sales and Growth Rate Analysis of Silence Therapeutics plc

    • Figure Revenue and Market Share Analysis of Silence Therapeutics plc

    • Table Product and Service Introduction of Silence Therapeutics plc

    • Table Company Profile and Development Status of Entremed, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Entremed, Inc

    • Figure Sales and Growth Rate Analysis of Entremed, Inc

    • Figure Revenue and Market Share Analysis of Entremed, Inc

    • Table Product and Service Introduction of Entremed, Inc

    • Table Company Profile and Development Status of ThromboGenics, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ThromboGenics, Inc.

    • Figure Sales and Growth Rate Analysis of ThromboGenics, Inc.

    • Figure Revenue and Market Share Analysis of ThromboGenics, Inc.

    • Table Product and Service Introduction of ThromboGenics, Inc.

    • Table Company Profile and Development Status of Aeterna Zentaris Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aeterna Zentaris Inc.

    • Figure Sales and Growth Rate Analysis of Aeterna Zentaris Inc.

    • Figure Revenue and Market Share Analysis of Aeterna Zentaris Inc.

    • Table Product and Service Introduction of Aeterna Zentaris Inc.

    • Table Company Profile and Development Status of Ångstrom Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ångstrom Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ångstrom Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ångstrom Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ångstrom Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Chugai Pharmaceutical Co., Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical Co., Ltd.

    • Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical Co., Ltd.

    • Figure Revenue and Market Share Analysis of Chugai Pharmaceutical Co., Ltd.

    • Table Product and Service Introduction of Chugai Pharmaceutical Co., Ltd.

    • Table Company Profile and Development Status of Alcon, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcon, Inc

    • Figure Sales and Growth Rate Analysis of Alcon, Inc

    • Figure Revenue and Market Share Analysis of Alcon, Inc

    • Table Product and Service Introduction of Alcon, Inc

    • Table Company Profile and Development Status of Astrazeneca plc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca plc.

    • Figure Sales and Growth Rate Analysis of Astrazeneca plc.

    • Figure Revenue and Market Share Analysis of Astrazeneca plc.

    • Table Product and Service Introduction of Astrazeneca plc.

    • Table Company Profile and Development Status of Cardium Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardium Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Cardium Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Cardium Therapeutics, Inc

    • Table Product and Service Introduction of Cardium Therapeutics, Inc

    • Table Company Profile and Development Status of Chugai Pharmaceutical Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical Co, Ltd

    • Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical Co, Ltd

    • Figure Revenue and Market Share Analysis of Chugai Pharmaceutical Co, Ltd

    • Table Product and Service Introduction of Chugai Pharmaceutical Co, Ltd

    • Table Company Profile and Development Status of Genentech, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc.

    • Figure Sales and Growth Rate Analysis of Genentech, Inc.

    • Figure Revenue and Market Share Analysis of Genentech, Inc.

    • Table Product and Service Introduction of Genentech, Inc.

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of F.Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F.Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F.Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F.Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F.Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Eisai, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai, Inc

    • Figure Sales and Growth Rate Analysis of Eisai, Inc

    • Figure Revenue and Market Share Analysis of Eisai, Inc

    • Table Product and Service Introduction of Eisai, Inc

    • Table Company Profile and Development Status of Antisoma plc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisoma plc.

    • Figure Sales and Growth Rate Analysis of Antisoma plc.

    • Figure Revenue and Market Share Analysis of Antisoma plc.

    • Table Product and Service Introduction of Antisoma plc.

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Imclone Systems, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Imclone Systems, Inc

    • Figure Sales and Growth Rate Analysis of Imclone Systems, Inc

    • Figure Revenue and Market Share Analysis of Imclone Systems, Inc

    • Table Product and Service Introduction of Imclone Systems, Inc

    • Table Company Profile and Development Status of Merck & Co., Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co., Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co., Inc.

    • Table Product and Service Introduction of Merck & Co., Inc.

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Bayer Healthcare AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare AG

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare AG

    • Figure Revenue and Market Share Analysis of Bayer Healthcare AG

    • Table Product and Service Introduction of Bayer Healthcare AG

    • Table Company Profile and Development Status of Merck & Co, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc.

    • Table Product and Service Introduction of Merck & Co, Inc.

    • Table Company Profile and Development Status of Progen Pharmaceuticals Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progen Pharmaceuticals Ltd.

    • Figure Sales and Growth Rate Analysis of Progen Pharmaceuticals Ltd.

    • Figure Revenue and Market Share Analysis of Progen Pharmaceuticals Ltd.

    • Table Product and Service Introduction of Progen Pharmaceuticals Ltd.

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US